Header cover image

Indian Pharmaceuticals & Biotech Established, Profitable and Undervalued

UPDATED Aug 08, 2022

Over $1bn in market cap, profitable and undervalued based on cash flows.

1 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
CIPLACipla₹1,029.552.5%12.8%₹830.8b₹1,098.05PE33.4xE17.4%0.5%
Page 1 of 1